Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sky Century InvestmentSKYI 27 Return-on-Tangible-Asset is -168.42% as of May. 2026. GuruFocus rates SKYI with a GF Score™ of 27/100. The stock has 6 warning signs investors should review. Among 1,007 Drug Manufacturers companies, Sky Century Investment ranks worse than 98.71% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Sky Century Investment's annualizedNet Income for the quarter that ended in May. 2026 was $-0.02 Mil. Sky Century Investment's average total tangible assets for the quarter that ended in May. 2026 was $0.01 Mil. Therefore, Sky Century Investment's annualized Return-on-Tangible-Asset for the quarter that ended in May. 2026 was -168.42%.
The historical rank and industry rank for Sky Century Investment's Return-on-Tangible-Asset or its related term are showing as below:
SKYI'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -2600 Med: -597.86 Max: -40
Current: -756.1
During the past 6 years, Sky Century Investment's highest Return-on-Tangible-Asset was -40.00%. The lowest was -2600.00%. And the median was -597.86%.
SKYI's Return-on-Tangible-Asset is ranked worse than 98.71% of 1007
companies
in the Drug Manufacturers industry
Industry Median: 3.04
vs SKYI: -756.10
Sky Century Investment (OTCPK:SKYI) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Sky Century Investment Return-on-Tangible-Asset Related Terms
Sky Century Investment Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Sky Century Investment's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sky Century Investment Return-on-Tangible-Asset Chart
SKYI vs SHPH, PLSH, CPMD: Return-on-Tangible-Asset Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Sky Century Investment's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sky Century Investment Return-on-Tangible-Asset vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sky Century Investment's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Sky Century Investment's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (May. 2026) net income data.
What does a Return-on-Tangible-Asset of -168.42% mean?
Sky Century Investment (SKYI) has a Return-on-Tangible-Asset of -168.42% as of May. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Sky Century Investment and its competitors. According to the industry distribution chart, Sky Century Investment ranks #994 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 98.7%.
Is Sky Century Investment's Return-on-Tangible-Asset too high?
Sky Century Investment's current Return-on-Tangible-Asset is -168.42%. Based on the distribution chart, Sky Century Investment ranks #994 out of 1007 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Sky Century Investment has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Sky Century Investment's Return-on-Tangible-Asset compare to SHPH and PLSH?
According to the Drug Manufacturers industry distribution chart, Sky Century Investment ranks #994 out of 1007 companies for Return-on-Tangible-Asset. This places Sky Century Investment in the lower half of its industry. The industry median Return-on-Tangible-Asset is 3.04. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Drug Manufacturers company?
The median Return-on-Tangible-Asset among Drug Manufacturers companies is 3.04, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Sky Century Investment and its competitors. For the Drug Manufacturers industry, the median Return-on-Tangible-Asset is 3.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sky Century Investment's current Return-on-Tangible-Asset is -168.42%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sky Century Investment stock overvalued right now?
Sky Century Investment (SKYI) has a current Return-on-Tangible-Asset of -168.42%. The current Return-on-Tangible-Asset is -168.42%. Sky Century Investment's overall GF Score™ is 27/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Sky Century Investment (SKYI), the current Return-on-Tangible-Asset is -168.42% as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sky Century Investment Inc operates four primary business lines, with profits generated from IT Services, including Technical Support and Server Leasing, and from the sale of RSS feeds and Podcasts. The IT Services segment provides ongoing technical support, maintenance, system upgrades, and high-performance server leasing, supporting growing demand for cloud solutions, data management, and network infrastructure. The Company also owns the Cannabis News application, a mobile platform that aggregates cannabis-related news from diverse sources and delivers real-time updates, though it is not commercially viable and has not generated revenue to date. The Company operates in competitive markets across IT services, marketing services, RSS feed services, and the cannabis industry.
27GF Score
Get the complete analysis for SKYI
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SKYI has been successfully added to your 
